- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Owens & Minor Inc (OMI)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: OMI (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $5.44
1 Year Target Price $5.44
| 2 | Strong Buy |
| 0 | Buy |
| 2 | Hold |
| 2 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -50.35% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 216.57M USD | Price to earnings Ratio - | 1Y Target Price 5.44 |
Price to earnings Ratio - | 1Y Target Price 5.44 | ||
Volume (30-day avg) 6 | Beta 1.36 | 52 Weeks Range 1.84 - 15.54 | Updated Date 01/9/2026 |
52 Weeks Range 1.84 - 15.54 | Updated Date 01/9/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -5.69 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -12.45% | Operating Margin (TTM) 8.08% |
Management Effectiveness
Return on Assets (TTM) 3.75% | Return on Equity (TTM) -196.39% |
Valuation
Trailing PE - | Forward PE 2.86 | Enterprise Value 2346313961 | Price to Sales(TTM) 0.02 |
Enterprise Value 2346313961 | Price to Sales(TTM) 0.02 | ||
Enterprise Value to Revenue 0.22 | Enterprise Value to EBITDA 98.73 | Shares Outstanding 77346594 | Shares Floating 61173421 |
Shares Outstanding 77346594 | Shares Floating 61173421 | ||
Percent Insiders 3.36 | Percent Institutions 97.45 |
Upturn AI SWOT
Owens & Minor Inc

Company Overview
History and Background
Owens & Minor Inc. was founded in 1901 by Earl Owens and George Minor in Richmond, Virginia. Initially, it was a small medical supply distributor. Over the decades, the company grew organically and through strategic acquisitions, expanding its product offerings and geographic reach. Key milestones include its public offering in 1970 and significant expansion into global markets and the development of its own manufactured products. The company has evolved from a regional distributor to a global healthcare logistics and medical products company.
Core Business Areas
- Product Distribution: Owens & Minor distributes a broad range of healthcare products, including medical supplies, surgical products, pharmaceuticals, and personal protective equipment (PPE). They serve hospitals, integrated delivery networks, and other healthcare providers.
- Global Manufacturing: This segment focuses on the manufacturing of medical and surgical products. This includes surgical drapes, gowns, masks, and other disposable medical textiles. They also produce sterile and non-sterile medical products.
- Apria Healthcare Integration: Following the acquisition of Apria Healthcare, Owens & Minor expanded into home healthcare services, including respiratory therapy, infusion services, and durable medical equipment. This segment aims to provide integrated patient care solutions.
Leadership and Structure
Owens & Minor is led by a Board of Directors and an executive management team. The current CEO is Michael J. Muldowney. The company operates through distinct business segments, primarily focused on its distribution, global manufacturing, and home healthcare operations.
Top Products and Market Share
Key Offerings
- Medical and Surgical Supplies: This encompasses a vast array of products used in healthcare settings, from basic consumables like bandages and gloves to specialized surgical instruments and implants. Market share data for specific products within this broad category is highly fragmented. Major competitors include Cardinal Health, McKesson, and Medline Industries.
- Personal Protective Equipment (PPE): During and after the COVID-19 pandemic, demand for PPE, including masks, gowns, and gloves, surged. Owens & Minor is a significant supplier of these items. Competitors include 3M, Ansell, and many other medical supply companies.
- Home Healthcare Services (via Apria): This includes services like oxygen therapy, sleep apnea treatment (CPAP devices), and infusion therapies. The market for home healthcare is growing rapidly. Key competitors include Lincare Holdings (a division of Linde), AdaptHealth, and Option Care Health.
Market Dynamics
Industry Overview
The healthcare distribution and medical products industry is characterized by its essential nature, driven by an aging population, increasing prevalence of chronic diseases, and advancements in medical technology. The industry is highly competitive and regulated, with significant focus on supply chain efficiency, product quality, and cost containment. The home healthcare segment is experiencing substantial growth due to the shift towards value-based care and patient preference for at-home treatment.
Positioning
Owens & Minor is positioned as a comprehensive healthcare solutions provider, bridging the gap between manufacturers and healthcare providers. Its competitive advantages lie in its extensive distribution network, growing manufacturing capabilities, and expanded presence in the high-growth home healthcare market through the Apria acquisition. The company aims to leverage its integrated model to offer end-to-end solutions for its customers.
Total Addressable Market (TAM)
The total addressable market for healthcare distribution and medical supplies is in the hundreds of billions of dollars globally. The home healthcare market is also a multi-billion dollar industry and is projected to grow significantly. Owens & Minor, through its diverse business segments, addresses a substantial portion of this TAM, though its market share within specific product categories varies.
Upturn SWOT Analysis
Strengths
- Extensive distribution network across the US and internationally.
- Diversified product portfolio including manufactured goods and services.
- Acquisition of Apria Healthcare significantly expands its home healthcare capabilities.
- Established relationships with a wide range of healthcare providers.
- Experience in managing complex supply chains.
Weaknesses
- High leverage and debt following the Apria acquisition.
- Potential integration challenges with Apria Healthcare.
- Reliance on a competitive and price-sensitive market.
- Vulnerability to supply chain disruptions and raw material costs.
Opportunities
- Growth in the home healthcare market due to aging demographics and preference for at-home care.
- Expansion of private label manufacturing and value-added services.
- Leveraging technology for improved supply chain efficiency and data analytics.
- Strategic partnerships and further acquisitions to enhance service offerings.
- Increased demand for medical supplies and PPE in emerging markets.
Threats
- Intense competition from large distributors and specialized manufacturers.
- Government regulations and reimbursement policy changes affecting healthcare providers and home care services.
- Economic downturns impacting healthcare spending.
- Cybersecurity threats and data breaches.
- Potential for consolidation within the industry, creating larger, more powerful competitors.
Competitors and Market Share
Key Competitors
- Cardinal Health (CAH)
- McKesson Corporation (MCK)
- Medline Industries (Private)
- Becton, Dickinson and Company (BDX)
- 3M Company (MMM)
- Baxter International (BAX)
- LHC Group (LHCG) (Acquired by Optum)
- AdaptHealth Corp (AHCO)
Competitive Landscape
Owens & Minor faces stiff competition from established giants like Cardinal Health and McKesson in the distribution space, and from specialized manufacturers in its product lines. Its advantage lies in its diversified approach, combining distribution, manufacturing, and now significant home healthcare services. The integration of Apria is critical for realizing its competitive potential in the growing home care segment, where it competes with players like AdaptHealth and the newly consolidated Optum-LHC Group.
Major Acquisitions
Apria Healthcare
- Year: 2022
- Acquisition Price (USD millions): 1550
- Strategic Rationale: To significantly expand its presence in the rapidly growing home healthcare market, adding respiratory therapy, infusion services, and durable medical equipment to its portfolio. This acquisition diversifies revenue streams and creates a more comprehensive healthcare solutions offering.
Medi-Care
- Year: 2020
- Acquisition Price (USD millions): 120
- Strategic Rationale: To strengthen its position in the reusable surgical textiles market and expand its global manufacturing capabilities, particularly in the production of surgical gowns and drapes.
Growth Trajectory and Initiatives
Historical Growth: Historically, Owens & Minor has experienced steady growth driven by its distribution business and strategic acquisitions. The acquisition of Apria Healthcare represents a significant step-change in its growth trajectory, aiming to capture a larger share of the expanding home healthcare market.
Future Projections: Future growth is expected to be driven by the successful integration and performance of Apria Healthcare, continued expansion in its manufacturing segment, and potential for further strategic acquisitions or partnerships. Analysts' projections will likely focus on revenue synergies from Apria, cost savings from integration, and market growth in home healthcare.
Recent Initiatives: The most significant recent initiative is the acquisition of Apria Healthcare, which has fundamentally reshaped the company's business model and market position. Other initiatives likely include optimizing its distribution network, enhancing its manufacturing capabilities, and investing in technology to improve operational efficiency and customer service.
Summary
Owens & Minor Inc. is undergoing a significant transformation following its large acquisition of Apria Healthcare, expanding its reach into the crucial home healthcare market. While this move promises substantial growth, it also brings considerable debt and integration challenges. The company's established distribution network and manufacturing capabilities provide a solid foundation, but its success hinges on effectively merging Apria's operations and managing its financial leverage amidst a competitive and evolving healthcare landscape.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Owens & Minor Inc. Investor Relations
- Company Annual Reports (10-K)
- Company Quarterly Reports (10-Q)
- Financial news and analysis websites (e.g., Yahoo Finance, Bloomberg)
- Industry research reports
Disclaimers:
This JSON output is for informational purposes only and does not constitute financial advice. The data presented is based on publicly available information and may not be exhaustive. Investment decisions should be made after consulting with a qualified financial advisor and conducting thorough due diligence. Market share data is an estimation based on available industry analysis and may not reflect precise current figures.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Owens & Minor Inc
Exchange NYSE | Headquaters Glen Allen, VA, United States | ||
IPO Launch date 1988-12-16 | President, CEO & Director Mr. Edward A. Pesicka | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 23200 | Website https://www.owens-minor.com |
Full time employees 23200 | Website https://www.owens-minor.com | ||
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Accendra Health, Inc. was formerly known as Owens & Minor, Inc. and changed its name Accendra Health, Inc. in December 2025. The company was founded in 1882 and is based in Glen Allen, Virginia.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

